Contact Us
Ribonucleic Acid (RNA) Editing Global Market Report 2025
Global Ribonucleic Acid (RNA) Editing Market Report 2025
Item added to cart!

Report Price : $4490.00

Pages : 250

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Ribonucleic Acid (RNA) Editing Global Market Report 2025

By Type (Messenger Ribonucleic Acid (RNA) Modification, Transfer Ribonucleic Acid (RNA) Modification, Ribosomal Ribonucleic Acid (RNA) Modification), By Technique (Insertion Or Deletion, Deamination), By Application (Cancer, Genetic Disorders, Temporary Maladies) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Ribonucleic Acid (RNA) Editing Market Overview

• Ribonucleic Acid (RNA) Editing market size has reached to $16.10 billion in 2024

• Expected to grow to $24.42 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%

• Growth Driver: Rising Genetic Disorders Drive Growth Of The Market Due To Increasing Parental Age And Mutation Correction Potential

• Market Trend: In Vivo Gene Editing And Strategic Collaborations Accelerate RNA-Based Therapies For Rett Syndrome

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Ribonucleic Acid (RNA) Editing Market?

Ribonucleic acid (RNA) editing is a post-transcriptional process that alters the nucleotide sequence of ribonucleic acid molecules after they are transcribed from deoxyribonucleic acid (DNA). This can change the resulting protein's structure or function, influencing gene expression and offering potential for therapeutic applications.

The main types of ribonucleic acid (RNA) editing are messenger ribonucleic acid (mRNA) modification, transfer ribonucleic acid (tRNA) modification, and ribosomal ribonucleic acid (rRNA) modification. Messenger RNA modification involves chemical changes to mRNA molecules after transcription, such as methylation or nucleotide sequence editing. The common techniques include insertion or deletion and deamination. These modifications have applications in areas such as cancer, genetic disorders, and temporary ailments.

Ribonucleic Acid (RNA) Editing Market Size and growth rate 2025 to 2029: Graph

What Is The Ribonucleic Acid (RNA) Editing Market Size 2025 And Growth Rate?

The ribonucleic acid (RNA) editing market size has grown strongly in recent years. It will grow from $16.10 billion in 2024 to $17.55 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to growing demand for transient and reversible editing methods, increasing use in neurodegenerative disease research, rising prevalence of rare and orphan diseases, growing interest in synthetic biology and bioengineering, and increasing academic and translational research initiatives.

What Is The Ribonucleic Acid (RNA) Editing Market Growth Forecast?

The ribonucleic acid (RNA) editing market size is expected to see strong growth in the next few years. It will grow to $24.42 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing prevalence of genetic disorders, growing focus on personalized medicine, increasing application in cancer treatment, rising advancements in delivery systems, and increasing support from government and regulatory bodies. Major trends in the forecast period include technological advancements in RNA editing platforms, advancements in in vivo delivery technologies, technological progress in sequencing and transcriptomics, developments in transient gene modulation techniques, and developments in synthetic biology applications.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Ribonucleic Acid (RNA) Editing Market Segmented?

1) By Type: Messenger Ribonucleic Acid (RNA) Modification, Transfer Ribonucleic Acid (RNA) Modification, Ribosomal Ribonucleic Acid (RNA) Modification

2) By Technique: Insertion Or Deletion, Deamination

3) By Application: Cancer, Genetic Disorders, Temporary Maladies

Subsegments:

1) By Messenger Ribonucleic Acid (MRNA) Modification: Base Editing, Adenosine Deaminase Acting On Ribonucleic Acid (RNA)-Mediated Editing, Site-Directed Ribonucleic Acid(RNA) Editing

2) By Transfer Ribonucleic Acid (TRNA) Modification: Pseudouridylation, Transfer Ribonucleic Acid Splicing, Inosine Modification

3) By Ribosomal Ribonucleic Acid (Rrna) Modification: Pseudouridylation, Ribosomal Ribonucleic Acid (RNA) Maturation Pathway Modulation, Site-Specific Ribosomal Ribonucleic Acid (RNA) Editing

What Is Driving The Ribonucleic Acid (RNA) Editing Market? Rising Genetic Disorders Drive Growth Of The Market Due To Increasing Parental Age And Mutation Correction Potential

The rise of genetic disorders is expected to propel the growth of the ribonucleic acid (RNA) editing market going forward. Genetic disorders are diseases caused by changes or mutations in the genetic material, either inherited from parents or arising spontaneously. The genetic disorders are increasing due to rising parental age, as older parents have a higher risk of passing on chromosomal abnormalities. Ribonucleic acid (RNA) editing helps treat genetic disorders by correcting mutations at the RNA level, allowing cells to produce functional proteins without altering the underlying DNA. For instance, in May 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, sickle cell disease (SCD) affects about 100,000 people in the United States. Therefore, the rise of genetic disorders is driving the growth of the ribonucleic acid (RNA) editing industry.

Who Are The Major Players In The Global Ribonucleic Acid (RNA) Editing Market?

Major companies operating in the ribonucleic acid (RNA) editing market are Moderna Inc., Arcturus Therapeutics Holdings Inc., CureVac AG, Beam Therapeutics Inc., EdiGene Inc., Ethris GmbH, Deep Genomics Incorporated, ProQR Therapeutics NV, ReCode Therapeutics, Capstan Therapeutics Inc., TriLink BioTechnologies, ADARx Pharmaceuticals Inc., Storm Therapeutics Limited, Ascidian Therapeutics Inc., Rznomics Inc., Airna Biotech S.L., hC Bioscience Inc., Korro Bio Inc., Shape TX, and Turn Biotechnologies.

What Are The Key Trends Of The Global Ribonucleic Acid (RNA) Editing Market? In Vivo Gene Editing And Strategic Collaborations Accelerate RNA-Based Therapies For Rett Syndrome

Major companies operating in the ribonucleic acid (RNA) editing market are focusing on developing innovative approaches, such as in vivo gene editing, to enable accurate and efficient correction of disease-causing mutations within living organisms. In vivo gene editing refers to the direct alteration of genes inside the cells of a living being to correct genetic abnormalities or modify gene activity for therapeutic use. For instance, in April 2024, the Rett Syndrome Research Trust, a US-based non-profit organization, launched the MECP2 Editing Consortium to advance gene editing treatments for Rett syndrome. This initiative brings together six leading laboratories to create DNA and RNA editing therapies that address the genetic cause of Rett syndrome, intending to accelerate their transition to clinical trials. Its collaborative framework promotes faster development by pooling expertise to deliver precise and potentially curative solutions for this serious neurological condition.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Ribonucleic Acid (RNA) Editing Market? Rznomics Partnered With Eli Lilly To Advance RNA-Editing Therapies For Hearing Loss

In May 2025, Rznomics Inc., a South Korea-based biopharmaceutical company, partnered with Eli Lilly and Company to develop and commercialize innovative RNA-editing therapies for sensorineural hearing loss utilizing Rznomics' trans-splicing ribozyme platform, with Rznomics overseeing early-stage research and Eli Lilly handling later-stage development and global commercialization. Eli Lilly and Company is a US-based pharmaceutical company investing in RNA editing to advance precise treatments for genetic and rare diseases.

What Is The Regional Outlook For The Global Ribonucleic Acid (RNA) Editing Market?

North America was the largest region in the ribonucleic acid (RNA) editing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Ribonucleic Acid (RNA) Editing Market?

The ribonucleic acid (RNA) editing market consists of revenues earned by entities by providing services such as therapeutic ribonucleic acid (RNA) editing services, ribonucleic acid (RNA) editing delivery optimization, and bioinformatics and data analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The ribonucleic acid (RNA) editing market also includes sales of ribonucleic acid (RNA) editing therapeutics, diagnostic kits, and ribonucleic acid (RNA) editing delivery systems. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Ribonucleic Acid (RNA) Editing Industry?

The ribonucleic acid (rna) editing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ribonucleic acid (rna) editing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Ribonucleic Acid RNA Editing Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $17.55 billion
Revenue Forecast In 2034 $24.42 billion
Growth Rate CAGR of 8.6% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered Type, Technique, Application
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Moderna Inc., Arcturus Therapeutics Holdings Inc., CureVac AG, Beam Therapeutics Inc., EdiGene Inc., Ethris GmbH, Deep Genomics Incorporated, ProQR Therapeutics NV, ReCode Therapeutics, Capstan Therapeutics Inc., TriLink BioTechnologies, ADARx Pharmaceuticals Inc., Storm Therapeutics Limited, Ascidian Therapeutics Inc., Rznomics Inc., Airna Biotech S.L., hC Bioscience Inc., Korro Bio Inc., Shape TX, and Turn Biotechnologies.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Ribonucleic Acid (RNA) Editing Market Characteristics

3. Ribonucleic Acid (RNA) Editing Market Trends And Strategies

4. Ribonucleic Acid (RNA) Editing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Ribonucleic Acid (RNA) Editing Growth Analysis And Strategic Analysis Framework

5.1. Global Ribonucleic Acid (RNA) Editing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Ribonucleic Acid (RNA) Editing Market Growth Rate Analysis

5.4. Global Ribonucleic Acid (RNA) Editing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Ribonucleic Acid (RNA) Editing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Ribonucleic Acid (RNA) Editing Total Addressable Market (TAM)

6. Ribonucleic Acid (RNA) Editing Market Segmentation

6.1. Global Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Messenger Ribonucleic Acid(RNA) Modification

Transfer Ribonucleic Acid(RNA) Modification

Ribosomal Ribonucleic Acid(RNA) Modification

6.2. Global Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Insertion Or Deletion

Deamination

6.3. Global Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cancer

Genetic Disorders

Temporary Maladies

6.4. Global Ribonucleic Acid (RNA) Editing Market, Sub-Segmentation Of Messenger Ribonucleic Acid(RNA) (Mrna) Modification, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Base Editing

Adenosine Deaminase Acting On Ribonucleic Acid(RNA)-Mediated Editing

Site-Directed Ribonucleic Acid (RNA) Editing

6.5. Global Ribonucleic Acid (RNA) Editing Market, Sub-Segmentation Of Transfer Ribonucleic Acid(RNA) (Trna) Modification, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pseudouridylation

Transfer Ribonucleic Acid Splicing

Inosine Modification

6.6. Global Ribonucleic Acid (RNA) Editing Market, Sub-Segmentation Of Ribosomal Ribonucleic Acid(RNA) (Rrna) Modification, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pseudouridylation

Ribosomal Ribonucleic Acid(RNA) Maturation Pathway Modulation

Site-Specific Ribosomal Ribonucleic Acid (RNA) Editing

7. Ribonucleic Acid (RNA) Editing Market Regional And Country Analysis

7.1. Global Ribonucleic Acid (RNA) Editing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Ribonucleic Acid (RNA) Editing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Ribonucleic Acid (RNA) Editing Market

8.1. Asia-Pacific Ribonucleic Acid (RNA) Editing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Ribonucleic Acid (RNA) Editing Market

9.1. China Ribonucleic Acid (RNA) Editing Market Overview

9.2. China Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Ribonucleic Acid (RNA) Editing Market

10.1. India Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Ribonucleic Acid (RNA) Editing Market

11.1. Japan Ribonucleic Acid (RNA) Editing Market Overview

11.2. Japan Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Ribonucleic Acid (RNA) Editing Market

12.1. Australia Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Ribonucleic Acid (RNA) Editing Market

13.1. Indonesia Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Ribonucleic Acid (RNA) Editing Market

14.1. South Korea Ribonucleic Acid (RNA) Editing Market Overview

14.2. South Korea Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Ribonucleic Acid (RNA) Editing Market

15.1. Western Europe Ribonucleic Acid (RNA) Editing Market Overview

15.2. Western Europe Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Ribonucleic Acid (RNA) Editing Market

16.1. UK Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Ribonucleic Acid (RNA) Editing Market

17.1. Germany Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Ribonucleic Acid (RNA) Editing Market

18.1. France Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Ribonucleic Acid (RNA) Editing Market

19.1. Italy Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Ribonucleic Acid (RNA) Editing Market

20.1. Spain Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ribonucleic Acid (RNA) Editing Market

21.1. Eastern Europe Ribonucleic Acid (RNA) Editing Market Overview

21.2. Eastern Europe Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Ribonucleic Acid (RNA) Editing Market

22.1. Russia Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Ribonucleic Acid (RNA) Editing Market

23.1. North America Ribonucleic Acid (RNA) Editing Market Overview

23.2. North America Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Ribonucleic Acid (RNA) Editing Market

24.1. USA Ribonucleic Acid (RNA) Editing Market Overview

24.2. USA Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Ribonucleic Acid (RNA) Editing Market

25.1. Canada Ribonucleic Acid (RNA) Editing Market Overview

25.2. Canada Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Ribonucleic Acid (RNA) Editing Market

26.1. South America Ribonucleic Acid (RNA) Editing Market Overview

26.2. South America Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Ribonucleic Acid (RNA) Editing Market

27.1. Brazil Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Ribonucleic Acid (RNA) Editing Market

28.1. Middle East Ribonucleic Acid (RNA) Editing Market Overview

28.2. Middle East Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Ribonucleic Acid (RNA) Editing Market

29.1. Africa Ribonucleic Acid (RNA) Editing Market Overview

29.2. Africa Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Ribonucleic Acid (RNA) Editing Market Competitive Landscape And Company Profiles

30.1. Ribonucleic Acid (RNA) Editing Market Competitive Landscape

30.2. Ribonucleic Acid (RNA) Editing Market Company Profiles

30.2.1. Moderna Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Arcturus Therapeutics Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. CureVac AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Beam Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. EdiGene Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Ribonucleic Acid (RNA) Editing Market Other Major And Innovative Companies

31.1. Ethris GmbH

31.2. Deep Genomics Incorporated

31.3. ProQR Therapeutics NV

31.4. ReCode Therapeutics

31.5. Capstan Therapeutics Inc.

31.6. TriLink BioTechnologies

31.7. ADARx Pharmaceuticals Inc.

31.8. Storm Therapeutics Limited

31.9. Ascidian Therapeutics Inc.

31.10. Rznomics Inc.

31.11. Airna Biotech S.L.

31.12. hC Bioscience Inc.

31.13. Korro Bio Inc.

31.14. Shape TX

31.15. Turn Biotechnologies

32. Global Ribonucleic Acid (RNA) Editing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ribonucleic Acid (RNA) Editing Market

34. Recent Developments In The Ribonucleic Acid (RNA) Editing Market

35. Ribonucleic Acid (RNA) Editing Market High Potential Countries, Segments and Strategies

35.1 Ribonucleic Acid (RNA) Editing Market In 2029 - Countries Offering Most New Opportunities

35.2 Ribonucleic Acid (RNA) Editing Market In 2029 - Segments Offering Most New Opportunities

35.3 Ribonucleic Acid (RNA) Editing Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Ribonucleic Acid (RNA) Editing Market, Sub-Segmentation Of Messenger Ribonucleic Acid(RNA) (Mrna) Modification, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Ribonucleic Acid (RNA) Editing Market, Sub-Segmentation Of Transfer Ribonucleic Acid(RNA) (Trna) Modification, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Ribonucleic Acid (RNA) Editing Market, Sub-Segmentation Of Ribosomal Ribonucleic Acid(RNA) (Rrna) Modification, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Ribonucleic Acid (RNA) Editing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Ribonucleic Acid (RNA) Editing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Moderna Inc. Financial Performance
  • Table 78: Arcturus Therapeutics Holdings Inc. Financial Performance
  • Table 79: CureVac AG Financial Performance
  • Table 80: Beam Therapeutics Inc. Financial Performance
  • Table 81: EdiGene Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Ribonucleic Acid (RNA) Editing Market, Sub-Segmentation Of Messenger Ribonucleic Acid(RNA) (Mrna) Modification, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Ribonucleic Acid (RNA) Editing Market, Sub-Segmentation Of Transfer Ribonucleic Acid(RNA) (Trna) Modification, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Ribonucleic Acid (RNA) Editing Market, Sub-Segmentation Of Ribosomal Ribonucleic Acid(RNA) (Rrna) Modification, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Ribonucleic Acid (RNA) Editing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Ribonucleic Acid (RNA) Editing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Moderna Inc. Financial Performance
  • Figure 78: Arcturus Therapeutics Holdings Inc. Financial Performance
  • Figure 79: CureVac AG Financial Performance
  • Figure 80: Beam Therapeutics Inc. Financial Performance
  • Figure 81: EdiGene Inc. Financial Performance

Frequently Asked Questions

Ribonucleic acid (RNA) editing is a post-transcriptional process that alters the nucleotide sequence of ribonucleic acid molecules after they are transcribed from deoxyribonucleic acid (DNA). This can change the resulting protein's structure or function, influencing gene expression and offering potential for therapeutic applications. For further insights on this market, request a sample here

The market major growth driver - Rising Genetic Disorders Drive Growth Of The Market Due To Increasing Parental Age And Mutation Correction Potential. For further insights on this market, request a sample here

The ribonucleic acid (RNA) editing market size has grown strongly in recent years. It will grow from $16.10 billion in 2024 to $17.55 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to growing demand for transient and reversible editing methods, increasing use in neurodegenerative disease research, rising prevalence of rare and orphan diseases, growing interest in synthetic biology and bioengineering, and increasing academic and translational research initiatives. The ribonucleic acid (RNA) editing market size is expected to see strong growth in the next few years. It will grow to $24.42 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing prevalence of genetic disorders, growing focus on personalized medicine, increasing application in cancer treatment, rising advancements in delivery systems, and increasing support from government and regulatory bodies. Major trends in the forecast period include technological advancements in RNA editing platforms, advancements in in vivo delivery technologies, technological progress in sequencing and transcriptomics, developments in transient gene modulation techniques, and developments in synthetic biology applications. For further insights on this market, request a sample here

The ribonucleic acid (RNA) editing market covered in this report is segmented
1) By Type: Messenger Ribonucleic Acid (RNA) Modification, Transfer Ribonucleic Acid (RNA) Modification, Ribosomal Ribonucleic Acid (RNA) Modification
2) By Technique: Insertion Or Deletion, Deamination
3) By Application: Cancer, Genetic Disorders, Temporary Maladies Subsegments:
1) By Messenger Ribonucleic Acid (MRNA) Modification: Base Editing, Adenosine Deaminase Acting On Ribonucleic Acid (RNA)-Mediated Editing, Site-Directed Ribonucleic Acid(RNA) Editing
2) By Transfer Ribonucleic Acid (TRNA) Modification: Pseudouridylation, Transfer Ribonucleic Acid Splicing, Inosine Modification
3) By Ribosomal Ribonucleic Acid (Rrna) Modification: Pseudouridylation, Ribosomal Ribonucleic Acid (RNA) Maturation Pathway Modulation, Site-Specific Ribosomal Ribonucleic Acid (RNA) Editing For further insights on this market,
request a sample here

North America was the largest region in the ribonucleic acid (RNA) editing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the ribonucleic acid (RNA) editing market are Moderna Inc., Arcturus Therapeutics Holdings Inc., CureVac AG, Beam Therapeutics Inc., EdiGene Inc., Ethris GmbH, Deep Genomics Incorporated, ProQR Therapeutics NV, ReCode Therapeutics, Capstan Therapeutics Inc., TriLink BioTechnologies, ADARx Pharmaceuticals Inc., Storm Therapeutics Limited, Ascidian Therapeutics Inc., Rznomics Inc., Airna Biotech S.L., hC Bioscience Inc., Korro Bio Inc., Shape TX, and Turn Biotechnologies. . For further insights on this market, request a sample here.

Major trends in this market include In Vivo Gene Editing And Strategic Collaborations Accelerate RNA-Based Therapies For Rett Syndrome. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon